Thermo Fisher Scientific Inc (NYSE:TMO) announced a quarterly dividend on Wednesday, July 12th, RTT News reports. Stockholders of record on Friday, September 15th will be paid a dividend of 0.15 per share by the medical research company on Monday, October 16th. This represents a $0.60 annualized dividend and a dividend yield of 0.34%. The ex-dividend date of this dividend is Thursday, September 14th.

Thermo Fisher Scientific has a payout ratio of 6.5% indicating that its dividend is sufficiently covered by earnings. Research analysts expect Thermo Fisher Scientific to earn $10.14 per share next year, which means the company should continue to be able to cover its $0.60 annual dividend with an expected future payout ratio of 5.9%.

Shares of Thermo Fisher Scientific (NYSE:TMO) opened at 176.33 on Monday. The stock has a 50 day moving average of $176.88 and a 200 day moving average of $164.14. Thermo Fisher Scientific has a one year low of $139.07 and a one year high of $182.87. The stock has a market cap of $68.77 billion, a P/E ratio of 30.72 and a beta of 1.06.

Thermo Fisher Scientific (NYSE:TMO) last released its earnings results on Wednesday, July 26th. The medical research company reported $2.30 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $2.27 by $0.03. The company had revenue of $5 billion during the quarter, compared to analyst estimates of $4.92 billion. Thermo Fisher Scientific had a net margin of 11.80% and a return on equity of 15.97%. The firm’s quarterly revenue was up 10.2% compared to the same quarter last year. During the same period in the prior year, the firm posted $2.03 EPS. On average, analysts forecast that Thermo Fisher Scientific will post $9.24 EPS for the current year.

COPYRIGHT VIOLATION NOTICE: “Thermo Fisher Scientific Inc Announces Quarterly Dividend of $0.15 (TMO)” was first published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this piece on another domain, it was illegally copied and reposted in violation of US and international trademark & copyright law. The legal version of this piece can be read at

In other news, CFO Stephen Williamson sold 2,500 shares of the stock in a transaction that occurred on Monday, June 5th. The stock was sold at an average price of $176.26, for a total transaction of $440,650.00. Following the completion of the transaction, the chief financial officer now directly owns 37,790 shares in the company, valued at approximately $6,660,865.40. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Marc N. Casper sold 20,000 shares of the stock in a transaction that occurred on Thursday, June 1st. The shares were sold at an average price of $172.79, for a total value of $3,455,800.00. Following the transaction, the chief executive officer now owns 269,279 shares of the company’s stock, valued at $46,528,718.41. The disclosure for this sale can be found here. Insiders have sold a total of 27,188 shares of company stock valued at $4,702,223 over the last quarter. Corporate insiders own 0.49% of the company’s stock.

TMO has been the subject of several analyst reports. Bank of America Corporation reissued a “buy” rating and issued a $210.00 target price (up from $200.00) on shares of Thermo Fisher Scientific in a report on Friday, July 21st. Zacks Investment Research lowered shares of Thermo Fisher Scientific from a “buy” rating to a “hold” rating in a report on Monday, July 31st. Barclays PLC set a $175.00 target price on shares of Thermo Fisher Scientific and gave the stock a “buy” rating in a report on Wednesday, April 26th. Cantor Fitzgerald initiated coverage on shares of Thermo Fisher Scientific in a report on Thursday, May 18th. They issued an “overweight” rating and a $194.00 target price for the company. Finally, Cowen and Company reissued an “outperform” rating and issued a $185.00 target price (up from $175.00) on shares of Thermo Fisher Scientific in a report on Saturday, April 29th. One research analyst has rated the stock with a hold rating, sixteen have given a buy rating and one has assigned a strong buy rating to the company’s stock. The stock presently has an average rating of “Buy” and an average price target of $188.56.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Dividend History for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Stock Ratings for Thermo Fisher Scientific Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific Inc and related stocks with our FREE daily email newsletter.